Additionally, studies propose that it may not be NMNAT2 and SARM1 proteins that are crucial targets; instead, it is suggested that downstream players in different pathways significantly participate in axon degeneration and subsequent neuropathy development. The gene discussed is NMNAT2; the disease is neuropathy.